The pathogenesis of Graves' ophthalmopathy
- PMID: 2415275
- DOI: 10.1016/s0300-595x(85)80037-2
The pathogenesis of Graves' ophthalmopathy
Abstract
The pathology of the orbital changes in Graves' ophthalmopathy (GO) has been discussed in detail. The target tissue is the eye muscle and the damage probably results from autoimmune processes. Cell-mediated immune responses have been demonstrated and an antibody to eye muscle is detectable in 70% of patients. There is no direct evidence for an effect of thyroid hormones or TSH on orbital tissues in GO. The relation between GO and autoimmune thyroid disease is discussed. Present evidence suggests that in GO autoimmune responses are directed to orbital tissue antigens and do not cross-react with thyroid antigens. Clinical studies suggest that all patients with hyperthyroidism have some abnormality of eye muscle, whereas not all patients with ophthalmopathy have evidence of thyroid disease. It is not possible at the present time to be certain whether GO is an integral part of Graves' disease or a separate entity.
Similar articles
-
Ophthalmopathic immunoglobulin in patients with Graves' ophthalmopathy.Lancet. 1984 Aug 18;2(8399):374-6. doi: 10.1016/s0140-6736(84)90543-9. Lancet. 1984. PMID: 6147455
-
Graves' ophthalmopathy.Can Med Assoc J. 1981 Apr 1;124(7):855-62, 866. Can Med Assoc J. 1981. PMID: 7011529 Free PMC article. Review.
-
A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity.Br Med J (Clin Res Ed). 1984 Apr 21;288(6425):1183-6. doi: 10.1136/bmj.288.6425.1183. Br Med J (Clin Res Ed). 1984. PMID: 6424781 Free PMC article.
-
Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid diseases.Thyroid. 1998 Feb;8(2):167-74. doi: 10.1089/thy.1998.8.167. Thyroid. 1998. PMID: 9510126
-
[The role of antibodies in Graves' ophthalmopathy].Orv Hetil. 1991 Sep 22;132(38):2097-100. Orv Hetil. 1991. PMID: 1923482 Review. Hungarian.
Cited by
-
Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy.BMJ. 1988 Dec 17;297(6663):1574-8. doi: 10.1136/bmj.297.6663.1574. BMJ. 1988. PMID: 2906260 Free PMC article.
-
Critical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature Search.Adv Ther. 2015 Jul;32(7):595-611. doi: 10.1007/s12325-015-0228-y. Epub 2015 Jul 23. Adv Ther. 2015. PMID: 26202828 Free PMC article.
-
Palmitate induced secretion of IL-6 and MCP-1 in orbital fibroblasts derived from patients with thyroid-associated ophthalmopathy.Mol Vis. 2012;18:1467-77. Epub 2012 Jun 4. Mol Vis. 2012. PMID: 22736938 Free PMC article.
-
Immunosuppressant therapy of thyroid eye disease.Klin Wochenschr. 1988 Nov 1;66(21):1049-59. doi: 10.1007/BF01711917. Klin Wochenschr. 1988. PMID: 3070148 Review.
-
Octreotide inhibits secretion of IGF-1 from orbital fibroblasts in patients with thyroid-associated ophthalmopathy via inhibition of the NF-κB pathway.PLoS One. 2021 Apr 22;16(4):e0249988. doi: 10.1371/journal.pone.0249988. eCollection 2021. PLoS One. 2021. PMID: 33886620 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical